3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Colorectal Neoplasms
44
Squamous Cell Carcinoma of Head and Neck
23
Carcinoma, Non-Small-Cell Lung
23
Head and Neck Neoplasms
13
Pancreatic Neoplasms
11
Neoplasm Metastasis
10
Carcinoma, Squamous Cell
8
Neoplasms
7
Lung Neoplasms
7
Colonic Neoplasms
7
Rectal Neoplasms
6
Esophageal Neoplasms
5
Carcinoma
5
Recurrence
4
Carcinoma, Renal Cell
4
Stomach Neoplasms
3
Neoplasms, Squamous Cell
3
Hereditary Sensory and Autonomic Neuropathies
3
Glioblastoma
3
Gastrointestinal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Colorectal Cancer Metastatic
3
Breast Neoplasms
3
Tongue Neoplasms
2
Sarcoma
2
Salivary Gland Neoplasms
2
Ovarian Neoplasms
2
Oligodendroglioma
2
Melanoma
2
Glioma
2
Interventions
pembrolizumab
4
Cisplatin
4
Gemcitabine
3
tocilizumab
1
spartalizumab
1
Vorinostat
1
Temozolomide
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Peripheral Blood Stem Cell Transplantation
1
Paclitaxel
1
Immunotherapy, Adoptive
1
Fluorodeoxyglucose F18
1
Filgrastim
1
FPP(RGD)2
1
Dexamethasone
1
Chemoprevention
1
Cetuximab
1
Bevacizumab
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Nasopharyngeal Neoplasms
×
Cetuximab
×
Clear all
NCT02507154
2018-08-21
NKEXPHNC
National University Hospital, Singapore
Phase 1/2
Unknown
31 enrolled